Head-to-head · computed 2026-08-11
Gala GLP-1 vs MEDVi
Gala GLP-1: Gala GLP-1 is an all-50-state compounded GLP-1 service offering a range of pricing by product tier, including a microdosing option. Its standard all-dose rate is $179/mo (tirz) and $179/mo (sema) with a microdosing tier starting at $149. MEDVi: MEDVi advertises a $179 semaglutide start that tiers to $299 at maintenance; tirzepatide is $399 flat.
Tirzepatide
| Gala GLP-1 | MEDVi | |
|---|---|---|
| All-in maintenance | $179/mo | $399/mo |
| Best plan rate | $179/mo | $399/mo |
| 12-month total | $2,148 | $4,788 |
| Status | Reported · 2026-07-14 | Provider-stated · 2026-08-05 |
The arithmetic
On the figures our desk holds, Gala GLP-1's $179 a month undercuts MEDVi's $399 by $220 a month at the 10 mg/wk maintenance basis — $2,640 across a year. Gala GLP-1's figure is reported (captured 2026-07-14) and MEDVi's is provider-stated (captured 2026-08-05); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Gala GLP-1's tirzepatide ladder runs $179 a month billed monthly, and $199 a month on a three-month plan. MEDVi's runs $399 a month billed monthly. On the twelve-month basis Gala GLP-1's $2,148 beats MEDVi's $4,788 by $2,640 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.
Semaglutide
| Gala GLP-1 | MEDVi | |
|---|---|---|
| All-in maintenance | $179/mo | $299/mo |
| Best plan rate | $179/mo | $299/mo |
| 12-month total | $2,148 | $3,588 |
| Status | Reported · 2026-07-14 | Provider-stated · 2026-08-05 |
The arithmetic
On the figures our desk holds, Gala GLP-1's $179 a month undercuts MEDVi's $299 by $120 a month at the 2.4 mg/wk maintenance basis — $1,440 across a year. Gala GLP-1's figure is reported (captured 2026-07-14) and MEDVi's is provider-stated (captured 2026-08-05); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Gala GLP-1's semaglutide ladder runs $179 a month billed monthly, and $199 a month on a three-month plan. MEDVi's runs $299 a month billed monthly. On the twelve-month basis Gala GLP-1's $2,148 beats MEDVi's $3,588 by $1,440 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.
Structure, side by side
Gala GLP-1
- MembershipNone
- Dose policyFlat at 'all doses' for standard plan; separate microdosing tier at $149
- Commitment3-month plan or standard monthly; confirm exact terms at enrollment
- CancellationPer provider terms
- PharmacyPartner 503A pharmacies (not named publicly)
MEDVi
- MembershipNone
- Dose policyTiered on semaglutide; tirzepatide flat
- CommitmentMonth-to-month
- CancellationCancel before renewal
- PharmacyPartner pharmacies
What our desk is watching on each
Gala GLP-1: Gala lists a range rather than one fixed price: the hero says $179/mo 'all doses', the FAQ says $199/mo 'with a 3-month plan', and $149/mo is listed for microdosing. This makes 'all-in maintenance' ambiguous; we rank on the $179 standard figure with a note. Exact ongoing rate must be confirmed at enrollment. Reported status from RangeYourself 2026-07-14.
MEDVi: Start-vs-maintenance spread on semaglutide; compare on maintenance.
Questions people ask
Is Gala GLP-1 or MEDVi cheaper in 2026?
The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.
What does Gala GLP-1 vs MEDVi miss that checkout will show?
Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.
Why do you compare at the maintenance dose instead of the starting dose?
Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.
What do Gala GLP-1 and MEDVi cost over a full year of tirzepatide?
On the plans our database holds, a year of tirzepatide runs $2,148 at Gala GLP-1 and $4,788 at MEDVi — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.
Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: Gala GLP-1 · MEDVi. Official sites: Gala GLP-1 ↗ · MEDVi ↗. Nothing here is medical advice.